
BPSDS provides end-to-end CMC development and formulation services for biologics to speed up development timelines. It uses Quality by Design, DOE, and AI/ML to design processes for RNA, proteins, mAbs, VLPs, and viral vectors. The firm supports tech transfer readiness and future regulatory submissions (IMPD/IND) with project-focused engagements. Its stance on sustainable manufacturing targets aligns with Net Zero objectives while offering scalable formulations and process investigations.

BPSDS provides end-to-end CMC development and formulation services for biologics to speed up development timelines. It uses Quality by Design, DOE, and AI/ML to design processes for RNA, proteins, mAbs, VLPs, and viral vectors. The firm supports tech transfer readiness and future regulatory submissions (IMPD/IND) with project-focused engagements. Its stance on sustainable manufacturing targets aligns with Net Zero objectives while offering scalable formulations and process investigations.